Professor Sir Nicholas J White
Contact information
Dori Castillo Aranda
adoracion.castilloaranda@ndm.ox.ac.uk
Podcast interview
Artemisinin therapy for malaria
Malaria kills more than half a million people every year. Following a number of groundbreaking clinical trials, Professor Sir Nick White and his Thailand team successfully demonstrated the effectiveness of artemisinin drug therapy for malaria in adults, children and infants. He also pioneered artemisinin combination therapy, the first-line treatment for malaria worldwide.
Research groups
Colleges
Nicholas White
FRS
Professor of Tropical Medicine
- Professor at Mahidol University in Thailand
Professor White’s diverse interests include the epidemiology, pathophysiology and management of uncomplicated and severe malaria, meliodosis, enteric fever, tetanus, dengue haemorrhagic fever, Japanese encephalitis and tuberculosis. His particular interests at present include the pathophysiology and treatment of severe malaria, the prevention of antimalarial drug resistance using artemisinin-based combinations. and the biology of relapse in vivax malaria.
Vivax malaria
Recent publications
-
Severe falciparum and vivax malaria on the Thailand-Myanmar border: A review of 1503 cases.
Chu CS. et al, (2023), Clin Infect Dis
-
Lineage-informative microhaplotypes for spatio-temporal surveillance of Plasmodium vivax malaria parasites.
Siegel SV. et al, (2023), medRxiv
-
The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria.
Watson JA. et al, (2023), BMC medicine, 21
-
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling WHK. et al, (2023), eLife, 12
-
The antimalarial activity of tafenoquine in falciparum malaria.
White NJ., (2023), Clin Infect Dis